Medivation

San Francisco, United States Founded: 2004 • Age: 22 yrs Acquired By Pfizer
Early-stage cancer therapeutics are acquired, developed, and partnered.

About Medivation

Medivation is a company based in San Francisco (United States) founded in 2004 was acquired by Pfizer in August 2016.. The company has 667 employees as of December 31, 2016. Medivation operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.

  • Headquarter San Francisco, United States
  • Employees 667 as on 31 Dec, 2016
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $100 M (USD), Debt – Conventional

    Sep 10, 2007

  • Investors
  • Employee Count
    667

    as on Dec 31, 2016

  • Acquired by
    Pfizer

    (Aug 22, 2016)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Medivation

  • Total Funding
  • Total Rounds 4
  • Last Round Debt – Conventional — $100.0M
  • First Round

    (01 Jun 2005)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2007 Amount Debt – Conventional - Medivation Valuation

investors

Dec, 2006 Amount Post-IPO - Medivation Valuation

investors

May, 2006 Amount Post-IPO - Medivation Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Medivation

Medivation has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Pfizer. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Pharmaceutical products for treating multiple diseases are provided.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Medivation

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Medivation

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Medivation Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Medivation

Medivation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Targeted and immune-oncology drugs for cancer treatment are developed.
domain founded_year HQ Location
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
domain founded_year HQ Location
Cancer therapies are developed using selective pathway inhibitors.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Medivation

Frequently Asked Questions about Medivation

When was Medivation founded?

Medivation was founded in 2004 and raised its 1st funding round 1 year after it was founded.

Where is Medivation located?

Medivation is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

How many employees does Medivation have?

As of Dec 31, 2016, the latest employee count at Medivation is 667.

What does Medivation do?

Medivation acquires early-development stage pharmaceuticals, develop those product candidates, and then partner or sell successful programs to larger companies. Their pipeline includes enzalutamide, an androgen receptor inhibitor approved for the metastatic castration-resistant prostate cancer (CRPC), and being further developed for earlier stages of prostate cancer, advanced breast cancer and hepatocellular carcinoma (Phase 3); Talazoparib (MDV3800), an orally available poly-ADP ribose polymerase, or PARP, inhibitor currently is in Phase 3 clinical trial for gBRCA mutated breast cancer (i.e., advanced breast cancer in patients whose BRCA genes contain germline mutations). They are targeting number of other solid tumor indications in including breast (beyond gBRCA mutations), prostate, small cell lung, and ovarian cancers and Pidilizumab (MDV9300), an antibody with immune-mediated anti-tumor effects, licensed from CureTechin 2014, in development for diffuse large B-cell lymphoma and other hematologic malignancies, such as multiple myeloma.

Who are the top competitors of Medivation?

Medivation's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.

Who are Medivation's investors?

Medivation has 1 investor. Key investors include Pfizer.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available